FIGURE 3.
Box plots of IL‐6, IL‐10 and sIL2R pre and post tocilizumab in SOT recipients stratified by COVID‐19 severity. (TOCI, tocilizumab)
Box plots of IL‐6, IL‐10 and sIL2R pre and post tocilizumab in SOT recipients stratified by COVID‐19 severity. (TOCI, tocilizumab)